Axim Biotechnologies Inc (AXIM): Deferred Revenue. $303,127

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Tuesday, 05/21/2024 12:28:53 AM

Tuesday, May 21, 2024 12:28:53 AM

Deferred Revenue.
$303,127 -
$250,148 =
$52,979 Revenue in Q1 2024

My wifi is not very good right now.
Maybe I will reply more next week.

Keep Last Read

Next 10 Prev Next

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/22/2024 08:53:56 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:24:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/21/2023 03:07:21 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/31/2023 08:10:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 05:35:50 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:11:37 PM

InvestorsHub NewsWire

Only $200 per official company press release!